A national clinical laboratory network for NCI precision oncology
Ended Awarded Last action
- Contract number
- HHSN26100054
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,534,220
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $38,534,220.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $38,534,220 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $38,534,220.00 cost-plus-fixed-fee delivery order contract to Leidos Biomedical Research Inc. to establish a National Clinical Laboratory Network in support of the NCI Precision Oncology program. This contract was not set aside.
Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. that specializes in biomedical research services for federal agencies. As the prime contractor, Leidos will provide a range of laboratory, clinical trial, and research support services for the NCI's precision oncology initiatives. Key subcontractors include Leica Microsystems Inc., Leica Biosystems Division, to provide microscopy equipment maintenance, and Life Technologies Corporation to deliver laboratory instruments, reagents, and associated repair services. This contract builds upon Leidos' existing work as a Federally Funded Research and Development Center (FFRDC) for the National Cancer Institute.
Quick answers
Who was awarded contract HHSN26100054?
HHSN26100054 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2017.
How much is contract HHSN26100054 worth?
The government has obligated $38,534,220 on HHSN26100054.
Is contract HHSN26100054 an order under another contract?
Yes. HHSN26100054 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100054 competed?
The extent of competition for HHSN26100054 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award